Fri, 11 Jun 2021 05:00:00 UT New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People With Spinal Muscular Atrophy (SMA)
Wed, 9 Jun 2021 15:04:00 UT CORRECTING and REPLACING Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
Wed, 9 Jun 2021 14:30:00 UT All Good Diapers Teams up With Ciara and Russell Wilson to Celebrate the New Generation of Parents and Babies Changing the World
Wed, 9 Jun 2021 13:00:00 UT Driscoll’s Kicks Off a Deeply Delicious Summer Season With the Return of Fan-Favorite Rosé Berries™
Wed, 9 Jun 2021 12:00:00 UT Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
